BCR and neoplasm: To this end, we utilized scRNA-seq and TCR/BCR sequencing to analyze the cancerous composition and immune community of a tumor lesion, malignancy ascites and peripheral blood from a chemotherapy-resistant relapsed HGSOC patient with progressively shorter progression-free survival (PFS) after several courses of platinum-based chemotherapy.